CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 91 filers reported holding CUE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,483 | -37.0% | 14,558 | 0.0% | 0.00% | – |
| Q2 2023 | $53,137 | -11.4% | 14,558 | +18.8% | 0.00% | – |
| Q1 2022 | $60,000 | -56.8% | 12,253 | 0.0% | 0.00% | – |
| Q4 2021 | $139,000 | -22.8% | 12,253 | -0.6% | 0.00% | – |
| Q3 2021 | $180,000 | +25.0% | 12,325 | 0.0% | 0.00% | – |
| Q2 2021 | $144,000 | -11.1% | 12,325 | -7.0% | 0.00% | – |
| Q1 2021 | $162,000 | -43.8% | 13,249 | -42.4% | 0.00% | -100.0% |
| Q4 2020 | $288,000 | -2.0% | 23,019 | +17.8% | 0.00% | 0.0% |
| Q3 2020 | $294,000 | +23.0% | 19,540 | +100.0% | 0.00% | 0.0% |
| Q2 2020 | $239,000 | +60.4% | 9,770 | -7.1% | 0.00% | – |
| Q1 2020 | $149,000 | -10.8% | 10,514 | 0.0% | 0.00% | – |
| Q4 2019 | $167,000 | – | 10,514 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |